PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients

DOI: 10.1080/2162402X.2016.1257454

Keywords: CD274, colorectal cancer, DNA methylation, immunotherapeutic, immunotherapies, immunotherapy, microsatellite instability, PD-L1, prognostic biomarker

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text